---
source: Differential Diagnosis in Small - Gough, Alex, Murphy, Kate.pdf
pages: 463
converted: 2026-02-01 19:52
part: chunk_023
estimated_tokens: 3900
---



erythropoietin deficiency, 347
haemoglobin synthesis,
defects, 347
iron deficiency, 347–8
normal, 345
nucleotide synthesis, defects, 347
pallor, 151
regenerative
haemolysis, 342–5
haemorrhage, 342
severe, 16, 379
anal sac/perianal disease
perianal/caudal pruritus, 182
perianal fistula, 182
perianal swelling, 182
anorexia/inappetence, 1, 7, 14, 21
diet, 11
mastication, 12
prehension, 12
primary, 11
psychological/behavioural
factors, 13
secondary, 11
swallowing, 12–13
anticoagulant toxicity, 40, 42, 44
antithrombin III, decreased
levels, 364
anuria/oliguria
post-renal, 116
pre-renal, 116
renal, 116
arrhythmias, 58, 133, 156, 157
cardiac disease, 160
severe, 152
arterial pulse alterations
hyperkinetic (bounding) pulse, 163
hypokinetic (weak) pulse, 163
pulse deficits, 164
pulsus alternans, 163
pulsus bigeminus, 164
pulsus paradoxus, 164
regional loss, pulse, 164


426 Index



ascites, 9, 137, 140, 150, 152, 155,
233, 254, 258–9, 375
abdominal ultrasonography, 306–8
bile, ruptured biliary tract, 306
blood, 307
chyle, 307
exudate, 307–8
severe, 150
transudate/modified transudate, 308
urine, lower urinary tract rupture, 308
aspartate aminotransferase
drugs/toxins, 320
haemolysis, 320
increased artefact, 320
ataxia
brainstem/central vestibular
disorders, 68–9
cerebellum
congenital, 69
degenerative, 69
drugs/toxins, 69
immune mediated/infectious, 69
metabolic, 70
neoplastic, 70
vascular, 70
forebrain
congenital, 67
degenerative, 67
immune-mediated disease/
infection, 67
metabolic, 68
neoplasia, 68
vascular, 68
peripheral nerves, 73–4
peripheral vestibular disease, 70–71
spine
congenital, 71
degenerative, 71–2
idiopathic, 72
immune mediated, 72
infectious, 72
neoplastic, 72–3



nutritional, 73
traumatic, 73
vascular, 73
systemic
drugs/toxins, 74–5
metabolic, 75
nutritional, 76
atrioventricular block, 417
first-degree, 413
second-degree, 413–14
third-degree, 414, 419
atrophy
disuse, 204
metabolic/endocrine/systemic
disease, 205
myopathies, 205
neurogenic, 205
azotaemia
post-renal, 324, 374
pre-renal, 324, 374


basophilia, 362
behaviour, altered
aggression, 84
extracranial disease, 84
inappropriate urination and
defecation, 84–5
intracranial disease, 82–4
stereotypy/compulsive behaviour, 85
bile acids/dynamic bile acid test, 322
failure to stimulate, 322
increased, 322
biliary obstruction, 297, 321, 388
bilirubin
decreased (minimal clinical
significance), 321
increased, 321–2
bilirubinuria, 117, 388
blindness/visual impairment, 12, 183
central nervous system (CNS),
90–91
intraocular/periocular, 91–3


Index 427



bony masses, skeletal radiography
neoplasia, 267–8
proliferative joint disease, 268
trauma, 268
bradyarrhythmias, 14–15, 18, 337
bradycardia, 163, 222, 353, 416
chronic, 291, 292
drugs/toxins, 160–161
metabolic disease, 161
sinus, 421–2
vagal tone (increased), 161
brainstem/central vestibular disorders
congenital, 68
degenerative, 68
drugs, 68
immune mediated/infectious, 68
metabolic, 68
neoplastic, 69
nutritional, 69
trauma, 69
vascular, 69
brainstem lesions, 85
buccal mucosal bleeding time
(increased)
thrombocytopathia, 362–3
thrombocytopenia, 362


calcification/mineral density,
abdominal
abdominal fat, 262
adrenal glands, 262
arteries, 262
gastrointestinal tract, 262
genital tract, 262
liver, 262–3
lymph nodes, 263
pancreas, 263
spleen, 263
urinary tract, 263
cardiac disease, 15, 127, 145, 150,
160, 163, 205, 222, 238, 292,
314, 337, 407, 418, 419, 421



cardiac tamponade, 134, 164, 259,
293, 298, 308
cardiorespiratory signs
historical
coughing, 51–2
dyspnoea/tachypnoea, 52
epistaxis, 55–6
exercise intolerance, 58–9
haemoptysis, 56–8
sneezing and nasal discharge, 53–4
physical
abnormal heart sounds, 156–60
abnormal respiratory sounds,
155–6
arterial pulse alterations, 163–4
ascites, 155
cyanosis, 153–5
dyspnoea/tachypnoea, 146–51
heart rate, abnormalities in,
160–162
jugular distension/hepatojugular
reflux, 163
pallor, 151
shock, 151–3
cataract, 91, 92, 93, 196, 200, 201
central nervous system (CNS)
brain disease, 90–91
disease, 27, 32, 50, 132, 153, 160,
217, 377, 379, 415
optic nerve disease, 91
central vestibular system
congenital conditions, 188
drugs/toxins, 188
idiopathic conditions, 188
immune-mediated/infection, 188
metabolic disease, 188
neoplasia, 189
nutrition, 189
vascular disorders, 189
cerebellar disease, 18, 66
cerebrospinal fluid (CSF) analysis,
398–400


428 Index



cerebrovascular accident, 20, 68, 69,
70, 81, 91, 189
chamber sizes, enlargement of
specific, 222
cholangiohepatitis, 6, 124, 143,
144, 259, 299, 308, 316,
318, 328, 396
cholangitis, 139, 143, 144, 316
cholecystitis, 139, 144, 258, 299,
317, 328
cholestasis, 143, 145, 239, 322, 336,
369, 395 _see also_ Jaundice
cholestatic disease, 322, 324
cholestatic liver disease, 321
cholesterol, 323–4
cirrhosis, 143, 145, 146, 239, 259,
297, 308, 316, 318, 328, 341
claw disease, 96, 98, 100, 102
drugs/toxins, 180–181
inherited/primary disease, 181
metabolic/endocrine disease, 181
neoplasia, 181
nutrition, 182
trauma, 182
vascular, 182
clotting disorder, 333
clotting factor deficiency, congenital,
40, 42, 44
clotting time, activated, 363–4
coagulation factor deficiency, 55, 58
coagulopathy, 40–44, 52, 54, 55, 64,
90, 117, 140, 196, 203, 216,
220, 229, 230, 237, 256, 258,
290, 299, 301, 303, 307, 309,
314, 329, 342, 348, 352,
364, 419
colitis, 31, 32, 38, 39, 44, 45, 48, 50,
139, 250, 304
coma, 127, 375, 422
coma/stupor
extracranial disease, 81–2
intracranial disease, 80–81



conjunctivitis
chemical, 192–3
immune-mediated, 193
infectious, 193
neoplastic, 194
neurological, 193
physical, 193
systemic diseases, 194
constipation, 31, 33, 50, 139, 246,
247, 248, 249, 250, 252
behavioural factors, 46
congenital conditions, 46
diet, 46
idiopathic conditions, 46
neuromuscular disease, 47
obstructive disease, 47
painful conditions, 47–8
prolonged colonic distension, 48
systemic disease, 48
corneal opacification
corneal oedema, 197–8
corneal vascularisation, 198
pigmentation, 198
corneal ulceration/erosion, 94,
197, 204
degeneration, 198
dystrophic, 198–9
infection, 199
inflammation/immune-mediated, 199
mechanical/irritant trauma,
199–200
neurological conditions, 200
cortisol (baseline/post-ACTH
stimulation test), 404
coughing
drugs/toxins/irritants, 51
infection, 51
inflammatory/immune-mediated
disease, 51
neoplasia, 52
pulmonary haemorrhage, 52
pulmonary oedema, 52


Index 429



cranial (intra) disease
congenital, 61–2, 80, 82
degenerative, 80, 83
drugs/toxins, 83
idiopathic, 62–3
infectious, 83
inflammatory/immune-mediated
disease, 63
inflammatory/infectious, 80
neoplasia, 63
neoplastic, 80–81, 84
physical, 64, 84
trauma, 81
vascular, 64, 81
cranial nerve (CN) responses, abnormal
anisocoria, 183
auditory response reduced, 183
CN V, 186
CN VII, 186
corneal reflex reduced, 183
facial asymmetry, 184
gag reflex reduced, 184
jaw tone reduced/inability to close
jaw, 184
lack of response, non-irritant
smell, 184
menace response reduced, 184
palpebral reflex reduced, 184
pupillary light reflex reduced, 185
response to stimulation, nasal
mucosa reduced, 185
response, vagal manoeuvres
reduced, 185
strabismus, 185
vestibulo-ocular reflex reduced, 185
C-reactive protein, 322–3
creatine kinase, 324–5
creatinine, 324
cyanosis
central, 153–5
heart disease, 58
peripheral, 153



deafness
congenital conditions, 85
degenerative disease, 85
drugs/toxins, 85–7
infection/inflammation, 87
mechanical, 87
neoplasia, 87
dehydration/hyperalbuminaemia, 366
dermatitis, inflammatory, 171
dermatological disease, 402
dermatological signs
alopecia, 172–4
anal sac/perianal disease, 182
claws disorders, 180–182
erosive/ulcerative skin disease, 174–5
historical, 59–61
nodules, 168–70
otitis externa, 176–8
pigmentation disorders, 170–172
pododermatitis, 178–80
pustules and papules, 166–7
scaling, 164–6
diaphragm abnormalities, thoracic
radiography
caudal displacement, 233
cranial displacement, 233
irregular diaphragmatic contour, 234
lack of visualisation of
diaphragmatic border, 234
diarrhoea, 6, 8, 45, 133, 152, 348,
369, 373, 375–7
gastrointestinal loss, 371
large intestinal, 250
diet, 36
drugs/toxins, 36–8
extra-intestinal conditions, 38
idiopathic conditions, 38
infection, 38–9
inflammatory/immune-mediated
disease, 39
neoplasia, 39–40
obstruction, 40


430 Index



diarrhoea ( _cont’d_ )
small intestinal
diet, 34
drugs/toxins, 34
extra-gastrointestinal disease, 34
idiopathic disease, 34
infection, 35
inflammatory/immune-mediated
disease, 35
motility disorders, 36
neoplasia, 36
distension, abdominal, 137–8
dwarfism, skeletal radiography, 265
dysphagia, 7
infectious/inflammatory disease, 26
neurological/neuromuscular
disease, 26
obstruction, 26
temporomandibular joint disease, 26
dyspnoea/tachypnoea, 52
drugs/toxins, 146
lower airway disorders, 148–50
physiological causes, 146–7
restrictive disorders, 150
systemic and miscellaneous
disorders, 150–151
upper airway disorders, 147–8
dystocia
foetal causes, 113
maternal causes, 112–13


effusion, 8, 133, 237, 242, 258, 271,
274, 314, 349, 372, 375
body cavity, 314
joint, 274
pericardial, 6, 15, 18, 116, 145, 152,
157, 164, 221, 222, 337, 412
pericardial disease, 239
thoracic ultrasonography, 290–291
pleural, 9, 11, 15, 21, 59, 150, 152,
154, 157, 215, 233–5, 242,
370, 376, 378, 380



thoracic radiography, 230–232
thoracic ultrasonography, 289
electrocardiographic findings
alterations
baseline, 416
P–R relationship, 413–14
P wave, 410–411
QRS complex, 411–13
Q–T interval, 415
in rate, 420–422
rhythm, 416–19
S–T segment, 414–15
T wave, 416
electrolyte
abnormalities, 68, 188
acid-base disorders, 68, 75,
133, 419
and blood gas findings
base excess, 381
bicarbonate, 381
chloride, 367–9
magnesium, 369–70
pa02, 379–81
pH, 377–9
phosphate, 373–4
potassium, 371–3
sodium, 375–7
total C02, 381
total calcium, 365–7
disturbances, 82, 415
imbalances, 65, 245, 246, 247, 248,
411, 414, 417
electromyographic findings
evoked activity, 423
spontaneous activity, 422
embryonic death, early, 104, 108
encephalitis, 24, 25, 62, 63, 67, 68, 83,
89, 130, 188, 399, 400
eosinopenia, 361
eosinophilia
hormonal, 360
immune mediated, 360


Index 431



infection, 360–361
neoplastic, 361
epilepsy, 20
epiphora/tear overflow, 93–4
epistaxis, 8, 41, 43, 54, 277,
342, 348
coagulopathies, 55
nasal disease, 55–6
exercise intolerance
cardiovascular disease, 58
drugs, 58
metabolic/endocrine disease, 58
neuromuscular/musculoskeletal
disease, 58–9
respiratory disease, 59
extracranial disease
CNS perfusion disturbances, 81
drugs/toxins, 64–5, 81–2
metabolic, 65, 82, 84
nutritional, 65, 82
eyes
intraocular masses, 309
point-like and membranous lesions,
vitreous chamber, 310
retinal detachment, 310
retrobulbar masses, 310


facial nerve, lesions, 193, 200
faecal analysis findings
blood, 408
culture
for enteropathogenic bacteria,
409
non-selective culture, 409
fungal infections, 409
parasites
cardiorespiratory, 408
flukes, 408
hookworms, 408
protozoa, 408
roundworms, 408
tapeworms, 408



threadworm, 409
whipworms, 409
undigested food residues, 409
faecal incontinence
anal sphincter incompetence, 49–50
reservoir incontinence, 50
faecal tenesmus/dyschezia
anal sac disease, 48
caudal abdominal mass, 48
colorectal disease, 48
constipation/obstipation, 48
diet, 48
pelvic narrowing, 49
perianal disease, 49
prostatic disease, 49
trauma, 49
urogenital disease, 49
ferritin, 325–6
fever, 8, 11, 21, 40, 42, 54, 62, 89,
129, 157, 159, 162, 163, 195,
219, 274, 338, 351, 353, 379,
383, 386, 399, 421
drugs/toxins, 121–2
immune-mediated disease, 122–3
immunodeficiency syndromes,
123–4
infection, 124–5
neoplasia, 126
tissue damage, 126
fibrin degradation products, 364
fibrinogen, 324, 326
fine-needle aspiration, cutaneous/
subcutaneous masses, 400–401
flatulence/borborygmus
aerophagia, 50
diet, 50
drugs/toxins, 50
malabsorption, 50
maldigestion, 50
folate, 326–7
forebrain disease, 85
forebrain dysfunction, 190


432 Index



fractures, skeletal radiography, 264
fructosamine, 327


gagging/retching
congenital disease, 24
inflammatory and infectious
disease, 24
neoplasia, 25
neurological disease, 25
nutrition, 25
respiratory disease (expectoration), 25
systemic disorders, 25
toxic, 25
trauma, 25
gamma-glutamyl transferase
drugs, 327
extrahepatic disease, 328
hepatic disease, 328
increased, 327
gastric/small intestinal obstruction,
250
gastrin, 328
gastrointestinal/abdominal signs
historical
constipation/obstipation, 46–8
diarrhoea, 34–40
dysphagia, 26
faecal incontinence, 49–50
faecal tenesmus/dyschezia, 48–9
flatulence/borborygmus, 50
gagging/retching, 24–5
haematemesis, 42–3
haematochezia, 44–6
melaena, 40–42
ptyalism/salivation/
hypersalivation, 22–4
regurgitation, 27–8
vomiting, 28–34
physical
abdominal distension, 137–8
abdominal pain, 138–41
abnormal liver palpation, 144–6



jaundice, 142–4
oral lesions, 135–7
perianal swelling, 141–2
gastrointestinal disease, 11, 14, 34, 40,
84, 161, 205, 274, 297, 311,
354, 372, 402, 411, 414, 416,
417, 422
abdominal pain, 139
abdominal ultrasonography,
304–5
acute vomiting, 31–2
chronic vomiting, 32–3
diffuse pain, 130
haematemesis, 42–3
haematochezia, 44
melaena, 41–2
glaucoma, 91, 92, 94, 183, 196–7,
198, 200, 201, 202, 203, 309
globulins
decreased, 329
increased, 329–30
monoclonal/oligoclonal, 330
glomerular filtration (reduced),
319–20
glomerulo-/tubulo-interstitial disease,
chronic generalised, 208
glucose, 330–332
growth failure
with good body condition, 13
with poor body condition, 14


haematemesis, 8, 342, 348
extra-gastrointestinal disease, 42
gastrointestinal disease, 42–3
ingestion of blood, 43
haematochezia, 40, 408
drugs, 44
gastrointestinal disease, 44
idiopathic conditions, 45
inflammatory/immune-mediated
disease, 45
neoplasia, 45


Index 433



obstructive disease, 45
parasitic, 45–6
haematuria, 8, 115, 117–18, 212, 342,
348, 383, 384, 390
haemoglobinuria, 117, 385, 388
haemolysis, 315, 316, 320–322, 326,
333, 335, 355, 365, 369, 372,
374, 384
immune mediated, 343–4
mechanical injury, red cells, 344–5
red cells, defects, 342–3
haemolytic/haemorrhagic
diseases, 360
haemoptysis
cardiovascular disease, 56
iatrogenic, 56–7
pulmonary disease, 57–8
systemic disease, 58
haemorrhage, 17, 25, 41, 42, 43, 64,
73, 78, 81, 90, 133, 142, 150,
152, 155, 156, 202, 216, 220,
229, 237, 256, 258, 288, 309,
310, 314, 319, 329, 348, 352,
355, 363, 364, 383, 384, 388,
412
chronic, 353
external, 342
hyphaema, intraocular, 92, 197
chronic glaucoma, 203
coagulopathy, 203
congenital disease, 203
hyperviscosity syndrome, 203
iatrogenic, 203
inflammation, 203
neoplasia, 203
neovascularisation, 203
retinal detachment, 203
systemic hypertension, 203
trauma, 203
internal, 342
pulmonary, 52
retinal lesions, 203



hair follicle damage, secondary to
pruritus, 173
head and neck radiography
frontal sinuses, 279
mandible, 276
maxilla, 275
nasal cavity, 277–8
pharynx, 279–80
soft tissues, 280, 281
tympanic bulla, 276–7
heart block, 14, 15, 18, 156, 157, 421
heart rate abnormalities
bradycardia, 160–161
tachycardia, 161–2
heart sounds
abnormal
murmurs, 159–60
transient heart sounds, 156–9
longer duration _see_ murmurs
transient
early diastolic sounds, 158–9
gallop rhythms, 158
loud S1, 156
loud S2, 157
quiet S1, 156–7
quiet S2, 157
split S1, 157
split S2, 157–8
systolic clicks, 159
hemineglect syndrome, 190
hepatic disease, 11, 34, 89, 106, 166,
173, 259, 297, 308, 316–20,
322, 328, 345, 362, 364, 379
hepatic encephalopathy, 23, 65, 66, 68,
75, 82, 84, 91, 188
hepatic failure/bile salt deficiency, 8,
20, 313, 331
hepatic insufficiency, 319, 323, 326,
329, 336
hepatic mass, 261, 319
hepatic neoplasia, 6, 318, 328
hepatic parenchymal disease, 322


434 Index

